Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) observed rebound of 17.61% since bottoming out at $5.28 on Aug. 18, 2017. Meanwhile, due to an ongoing pressure which caused a decline of almost -4.61% in the past five days, the stock price is now down -10.52% so far on the year - still in weak territory. In this case, shares are down -37.02% from $9.86 , the 52-week high touched on May. 24, 2017, but are collecting gains at -27.28% for the past 12 months.Anton Falk Target Price on INO Reaches $11.85
Anton Falk Capital Partners, is recommending investors to buy Inovio Pharmaceuticals, Inc. (INO)'s shares projecting a $11.85 target price. Analysts target price forecasts are a prediction of a stock's future price, generally over the 12 months following the release. This forecast is a point estimate that provides investors with a benchmark against which to directly compare stock price in the short run. Target prices made by analysts employed by Anton Falk Capital Partners, who have access to a greater resource pool, are more likely to be met over the 12-month forecast period.
How Quickly Inovio Pharmaceuticals, Inc. (INO)'s Sales Grew?
INO's revenue has grown at an average annualized rate of about 29.3% during the past five years. However, the company's most recent quarter increase of 229% looks attractive. The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. It tells an investor how quickly a company is increasing its revenues. The sales growth rate helps investors determine how strong the overall growth-orientation is for a stock or portfolio.